Viking Therapeutics announced its new Chief Commercial Officer, Neil Aubuchon, on Jan. 7, 2026. Viking is a clinical-stage ...
Halozyme Therapeutics Inc. and Skye Bioscience Inc. have entered a non-exclusive global collaboration and license agreement.
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
Boardwalktech Software Corp. ("Boardwalktech" or the "Company"), a provider of patented digital ledger and AI?enabled enterprise software, announces the expansion and extension of its contract with a ...
Integration of prescription drug dispensing optimization aritifical intelligence platform EinsteinRx into pharmacy client point-of-sales systems has commencedEinsteinRx integration streamlining effort ...
Integration of prescription drug dispensing optimization aritifical intelligence platform EinsteinRx™ into pharmacy client point-of-sales systems has commencedEinsteinRx integration streamlining ...
Patients with overweight/obesity receiving branded semaglutide via a nationwide telehealth platform achieve weight-loss ...
Waist Circumference Reduction of 9.8 cm at Day 54Significant Direct Hepatic Activity with a 23.7% Reduction in Liver ...
AI, trust, wellness, value, authenticity and proof-led sustainability with real-world examples and brand action ...
New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...
SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing in ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback